BSECompany Update4h ago · 11 Aug 2026, 04:23 pm
Monitoring Agency Report for the quarter ended 30.06.2026
Nexome Capital Markets Ltd · 508905
✦ AI SummaryResults
Nexome Capital Markets Ltd has submitted a Monitoring Agency Report for the quarter ended 30.06.2026, as required by SEBI regulations, detailing the utilization of funds raised through a Rights Issue of equity shares. The report, issued by CARE Ratings Limited, indicates that the proceeds have been used appropriately for the objects mentioned in the offer document.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Nexome Capital Markets Ltd - 508905 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Attachments (1)
📄pdf
Download →
c533dd67-864c-4d95-8aa3-b61a5b0e3939.pdf
View document text
NEXO)ME CAPITAL MARKETS LIMITED
(formerly SMIFS Capital Markets Limited)
August 11, 2026
The Secretary
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street
Mumbai-400 001
Dear Sirs,
Sub: Monitoring Agency Report for the quarter ended 30th lune, 2026.
Ref: Regulation 32(6) of Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015, read with Regulation 82(4) of the
Securities and Exchange Board of India (Issue of Capital and Disclosure
Requirement) Regulations, 2018.
Pursuant to Regulation 32(6) of Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015, read with Regulation 82(4) of the
Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement)
Regulations, 2018, please find enclosed herewith Monitoring Agency Report for the quarter
ended 30th June, 2026, issued by CARE Ratings Limited in respect of utilization of funds
raised through Rights Issue of equity shares of the Company issued vide its Letter of Offer
dated 24th February, 2026. The proceeds from Rights Issue have been utilized
appropriately for the objects mentioned in the offer document.
The said report is reviewed and approved by the Audit Committee and thereafter approved
by Board of Directors of the Company.
This intimation is also uploaded on the website of the Company at www.nexomecap.com.
You are requested to take the same on record.
Yours faithfully,
For Nexome Capital Markets Limited
(Formerly SMIFS Capital Markets Limited)
Sanjana Gupta
Company Secretary cum Compliance Officer
Encl: a/a
Regd. Office: "VAIBHAV" (4F), 4 Lee Road, Kolkata - 700 020 •Ph.: 033-2290-7400/740l/7402
E-mail : smifcap@gmail.com, ncml@ncxomegroup.com •Website: www.nexomecap.com
CIN No. : L 74300WBJ 983PLC036342
Monitoring Agency Report
CareEdge
RATINGS
No. CARE/HO/GEN/2026-27/1131
The Board of Directors
Nexome Capital Markets Limited
4th floor, Vaibhav Building,
Kolkata, West Bengal, India, 700020
August 11, 2026
Dear Sir/Ma’am,
Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Rights issue of Nexome
Capital Markets Limited (“the Company”)
We write in our capacity of Monitoring Agency for the Rights Issue for the amount aggregating to Rs. 22.04 crore of the
Company and refer to our duties cast under 82 of the Securities & Exchange Board of India (Issue of Capital & Disclosure
Requirements) Regulations.
In this connection, we are enclosing the Monitoring Agency Report for the quarter ending June 30, 2026, as per aforesaid
SEBI Regulations and Monitoring Agency Agreement dated January 30, 2026.
Request you to kindly take the same on records.
Thanking you,
Yours faithfully,
Yogesh Rochani
Assistant Director
Yogesh.rochani@careedge.in
Report of the Monitoring Agency
Name of the issuer: Nexome Capital Markets Limited
For quarter end: June 30, 2026
Name of the Monitoring Agency: CARE Ratings Limited
(a) Deviation from the objects: Not applicable
(b) Range of Deviation: Not applicable
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of
the issue based on the information provided by the Issuer and information obtained from sources believed by it to be
accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/
certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which
accepts no responsibility whatsoever, for loss or damage from the use of the said information. The views and opinions
expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever.
Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA
and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as
defined under Section 2(38) of the Companies Act, 2013.
The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains
and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no
conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the
issuer, or while undertaking credit rating or other commercial transactions with the entity.
We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where
applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be
captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their
report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed
by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board.
Signature:
Name and designation of the Authorized Signatory: Yogesh Rochani
Designation of Authorized person/Signing Authority: Assistant Director
1) Issuer Details:
Name of the issuer : Nexome Capital Markets Limited
Name of the promoter : Progressive Star Finance Private Limited, Stewart Investment And Finance Private Limited, Lend Lease Company (India) Limited,
Nilangi Parekh, Utsav Parekh, Vivaan And Keya Trust, Araiya And Kiaan Trust, Samarth Parekh and Saharsh Parekh
Industry/sector to which it belongs : SEBI Registered Merchant Banker
2) Issue Details
Issue Period : March 13, 2026, to March 23, 2026
Type of issue (public/rights) : Rights issue
Type of specified securities : Equity shares
IPO Grading, if any : NA
Issue size (in crore) : Rs. 22.04 crore
3) Details of the arrangement made to ensure the monitoring of issue proceeds:
Source of information /
certifications considered Comments of the Comments of the
Particulars Reply
by Monitoring Agency for Monitoring Agency Board of Directors
preparation of report
The funds have been utilized in accordance with the
objectives stated in the Letter of Offer.
Further, the Rights Issue Committee, passed a
resolution approving the deployment of GCP funds
• CA Certificate*
towards investments, as such investments were
• Management
considered to directly support the company's ongoing
certificate
strategic initiatives, business expansion plans,
• Rights Issue
Whether all utilization is as per the working capital requirements, capital expenditure,
Yes Committee resolution No comments
disclosures in the Offer Document? administrative expenses, and other operational
for GCP utilization
needs.
• Mutual fund
However, CareEdge Ratings' monitoring scope
statement
remains limited with respect to the end utilization of
• Bank statements
these funds. As the deployment was undertaken
pursuant to the approval of the Rights Issue
Committee and the funds have been invested in units
of mutual funds, CareEdge Ratings is able to monitor
Source of information /
certifications considered Comments of the Comments of the
Particulars Reply
by Monitoring Agency for Monitoring Agency Board of Directors
preparation of report
the utilization only up to the level of such investments
and not the subsequent deployment/redemption of
the underlying mutual fund investments.
Whether shareholder approval has been
• CA Certificate*
obtained in case of material deviations# Not applicable as there have been no material
Not applicable • Management No comments
from expenditures disclosed in the Offer deviations.
certificate
Document?
Whether the means of finance for the
• Management
disclosed objects of the issue have Not applicable No comments No comments
certificate
changed?
• Previous Monitoring
Is there any major deviation observed over No, there are no deviations observed from last
No Agency Report No comments
the earlier monito
[Showing first 8,000 characters — download PDF for full document]